Abstract
Diagnostic classification of depressive patients according to biological criteria has been a goal for many years. Many different variables have been suggested and tested, but as yet none of the biological substances suggested has shown a clear link to the illness.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Åsberg M, Scalling D, Traskman-Bentz L, Wagner A (1987) Psychobiology of suicide, impulsivity and related phenomena. In: Meltzer HY (ed) Psychopharmacology. The third generation of progress. Raven, New York, pp 655–668
Bech P, Eplov L, Gastpar M, Gentsch C, Mendlewicz J, Plenge P, Rielaert C, Mellerup ET (1988) WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. Pharmacopsychiatry 21: 147–150
Briley MS, Raisman R, Langer SZ (1979) Human platelets possess high-affinity binding sites for 3H-imipramine. Eur J Pharmacol 58: 347–348
Briley MS, Langer SZ, Raisman R, Sechter D, Zarafian E (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209: 303–305
Galzin AM, Poirier MF, Loo H, Sechter D, Zarafian E, Langer SZ (1988) 3H-paroxetin binding to platelets from healthy volunteers and depressed patients. Br. J Pharmacol 93: 12P
Langer SZ, Raisman R (1983) Binding of 3H-imipramine and 3H-desimipramine as biochemical tools for studies in depression. Neuropharmacology 22: 407–413
Langer SZ, Moret C, Raisman R, Dubocovich ML, Briley M (1980) High-affinity 3H- imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science 210: 1133–1135
Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E (1987) Association of 3H- imipramine and 3H-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression. J Recept Res 7: 499–521
Mellerup ET, Plenge P, Rosenberg R (1982) 3H-imipramine binding sites in platelets from psychiatric patients. Psychiatry Res 7: 221–227
Meltzer HY, Lowy MT (1987) The serotonin hypothesis of depression. In: Meltzer HY (ed) Psychopharmacology. The third generation of progress. Raven, New York, pp 513–526
Plenge P, Mellerup ET, Gjerris A (1988) Imipramine binding in depressive patients, diagnosed according to different criteria. Acta Psychiatry Scand 78: 156–161
Poirier MF, Benkelfat C, Loo H, Sechter D, Zarifian E, Galzin AM, Langer SZ (1986) Reduced Bmax of 3H-imipramine binding to platelets of depressed patients free of previous medication with 5HT inhibitors. Psychopharmacology 89: 456–461
Potkin S, Langer S, Mellerup ET (1988) The validity of platelet 3H-imipramine binding as a marker in depression. Neuropsychopharmacology. XVI C.I.N.P. Congress, Munich, August 15–19, 1988
Raisman R, Briley M, Langer SZ (1979) Specific tricyclic antidepressant binding sites in rat brain. Nature 281: 148–150
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Plenge, P., Mellerup, E.T. (1990). Platelet Binding Sites for Serotonin Uptake Inhibitors: Is [3H]Imipramine Binding Decreased in Depression?. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-74034-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74036-7
Online ISBN: 978-3-642-74034-3
eBook Packages: Springer Book Archive